This episode currently has no reviews.
Submit ReviewThere’s been an explosion of interest in women’s health recently. The category, deemed ‘femtech’ by some, is currently a $700m market that’s expected to boom to more than $1 billion by 2025. Of course, women’s health isn’t new, so what, exactly, is different about today's momentum? That’s the question we asked in the latest episode of “License to Accelerate: Perspectives on the Future of Health” that features Jess Graham, chief marketing officer at Hologram Sciences; Bulbul Hooda, brand creator and chief marketing officer at Vella Bioscience; and Michelle Webb who leads the health practice at Allison+Partners. The conversation is moderated by PRovoke Media executive editor Aarti Shah. 03:08 More about Hologram Sciences and Vella Bioscience
06:38 Why we should examine the use of ‘femtech’
07:21 Medical terms vs. euphemisms for women’s health
10:16 Social media restrictions on feminine health
13:49 How to build trust around such intimate offerings
17:48 Inclusive storytelling on women’s health
21:26 How data is driving storytelling on women’s health
24:16 Combating ageism against women
27:10 Where is the conversation headed?
29:40 How to stand out in such a crowded, buzz-generating space?
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review